These macrophages in subjects with co-morbidities consistently associated with the increased risk of mortality of the disease COVID-19 (neoplasms, COBP) are PD-L1+ and despite their role in the pathophysiology of these pathologies they still have a finalistic significance in reducing hyper-inflammation potentially lethal in the lungs. This evidence concerns the gene CD274 and COVID-19.